Do Novel Biomarkers Have Utility in the Diagnosis and Prognosis of AKI?: Commentary

Kidney360. 2023 Dec 1;4(12):1670-1671. doi: 10.34067/KID.0000000000000240.

Author

Edward D Siew¹

Affiliation

¹ Division of Nephrology and Hypertension, Vanderbilt Center for Kidney Disease (VCKD) and Integrated Program for Acute Kidney Injury (AKI), Vanderbilt University Medical Center, Nashville, Tennessee and Tennessee Valley Health Systems (TVHS), Nashville Veterans Affairs Hospital, Tennessee.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Comment

MeSH terms

Acute Kidney Injury* / diagnosis
Biomarkers
Humans
Prognosis

Substances

Biomarkers

Grants and funding

P30 DK114809/DK/NIDDK NIH HHS/United States